Treatment of the intraabdominal abscesses through percutaneous ultrasound-guided drainage in oncological patients: Clinical and microbiological data.

AIM OF THE STUDY: Oncological patients are particularly prone to the onset of septic complications such as abdominal abscesses. The aim of our study was to analyze clinical and microbiological data in a population of oncological patients, submitted to percutaneous ultrasound-guided drainage (PUD) for postoperative abdominal abscesses. PATIENTS AND METHODS: Data from 24 patients operated on for neoplastic pathologies and treated with PUD for abdominal abscesses during the postoperative period were reviewed. In all cases cultural examination with antibiogram was performed. RESULTS: In 5 out of 24 patients (20.8%), the abdominal abscesses appeared after the discharge, with a mean hospital stay of 34.2 +/- 24.9 days. In six out of 24 patients (25%) there were multiple abscesses localizations. The cultural examination was positive in 23 patients and negative only in one patient. Abscesses localized only in the upper abdominal regions had a significant prevalence of monomicrobial cultural examinations (57.1%) with respect to the results for abscesses placed in the lower abdominal regions, that were polymicrobial in 88.8% of cases (p = 0.027). An antibiogram demonstrated a stronger activity of beta-lactamines, chinolones, and glycopeptides with respect to aminogycosides, cephalosporins, and metronidazole. CONCLUSIONS: In oncological patients, the planning of the empiric antibiotic therapy should be based on the anatomotopographic localization of the abdominal abscess and on the typology of the operation performed giving preference to beta-lactamines, chinolones and glycopeptides.

[Empiric antibiotic therapy in the treatment of postoperative abdominal abscesses. Clinical and microbiological data]. / Antibioticoterapia empirica nel trattamento degli ascessi addominali postoperatori. Dati clinici e microbiologici.

Abdominal abscesses arising postoperatively constitute a serious problem, particularly in the field of oncological surgery. The aim of our study was to interpret clinical and microbiological data relating to a population of oncological patients, undergoing ultrasound-guided drainage for postoperative abdominal abscesses, so as to be able to better plan empiric antibiotic therapy. We therefore retrospectively analysed the data of 24 patients operated on for neoplastic pathologies and treated with ultrasound-guided percutaneous drainage for abdominal abscesses during the postoperative period. Microbiological and clinical data showed that abscesses located in the lower abdominal regions almost always present a polymicrobial growth, though abscesses in the upper regions are more frequent. Moreover, the antibiotic assay results prompted us to consider the use of beta-lactamines, quinolones and glycopeptides more favourably, in view of their greater efficacy against the microbes tested. Thus, the planning of empiric antibiotic therapy should be based above all on the anatomical-topographic location of the abdominal abscess and on the type of operation performed, with thorough assessment of the use of the above-mentioned antibiotics.

Treatment of small hepatocellular carcinoma: a comparison of techniques and long-term results.

OBJECTIVE: The aim of this study was to compare the results over time of transcatheter arterial chemoembolization (TACE), percutaneous ethanol injection (PEI), laser thermal ablation (LTA) and combined therapy in the treatment of small hepatocellular carcinoma. METHODS: Between 1998 and 2004, 131 cirrhosis patients (99 Child-Pugh class A, 32 Child-Pugh class B) with a small hepatocellular carcinoma were included in the study; 34 were treated with PEI, 46 with LTA, 18 with TACE and 33 with combined therapy. RESULTS: No major complication occurred during any procedure. Computed tomography scan showed that complete necrosis was achieved in 81% of treated nodules (120 out of 148); as a whole, the disease relapsed in 42 (32.0%) patients (with a disease-free interval of 17.0+/-13.7 months). The cumulative survival rates were 81.9, 35.7 and 20.8% at 12, 36 and 60 months respectively. A univariate analysis of survival showed statistically significant differences in the comparison between Child-Pugh class A with respect to Child-Pugh class B (P<0.0001) and between nodules with a diameter of 20 mm or less as opposed to larger than 20 mm (P=0.001). Patients subjected to LTA showed a statistically significant longer survival than those treated with TACE and PEI. CONCLUSIONS: LTA proves to be the most effective treatment, affording reduced invasiveness, a limited number of sessions, complete necrosis in almost all cases and better total survival in the treated patients.

Pathogenesis and evolution of carpal instability: imaging and topography.

Carpal instability is a biomechanical alteration with a multiple pathogenesis which, if not identified and treated in time, leads to gradual articular collapse. Traumatism is known to be one of the main causes of carpal instability, while deposits of microcrystals caused by metabolic (chondrocalcinosis and gout) and congenital (ulna minus variance) diseases are less frequently involved in the pathogenesis. In forms secondary to traumatism, the trauma causes ligamentous injuries that lead to misalignments of the joint surfaces, or badly healed fractures with consequent articular incongruency. In both situations, an alteration of carpal kinematics is generated and, if normal carpal biomechanics are not restored, this alteration leads, over the course of time, to degenerative alterations of the cartilage, followed by chondral erosions and to the exposure of the bone. We present the etiology, topography and consequences of carpal instability, discussing the diagnostic procedure, which always begins with a conventional X-ray examination, followed by a CT and/or an MRI with an intra-articular injection of contrast medium as the gold standard for a correct evaluation. Our aim is to present and compare the different patterns of carpal instability observed in our Radiology Institute with those found in literature.

US, MRCP, CCT and ERCP: a comparative study in 131 patients with suspected biliary obstruction.

BACKGROUND: Recent years have witnessed a rapid and continuous evolution in the diagnosis of biliary obstructive disease. Traditional methodologies, such as US (ultrasonography), CT (computed tomography), ERCP (endoscopic retrograde cholangiopancreatography) and PTC (percutaneous transhepatic cholangiography), have been supplemented by MRCP (magnetic resonance cholagiopancreatography) and CCT (cholangio computed tomography) The purpose of our study was to compare the reliability of diagnostic US, MR and other imaging techniques in intrinsic biliary obstructive disease. MATERIAL/METHODS: Between June 1999 and July 2003 we conducted a prospective study on 131 patients--60 males and 71 females--ranging in age from 37 to 79 years, with clinical features of biliary obstructive disease. Imaging studies were done on each patient using several different techniques. The US, MRCP, CCT and ERCP results were read by radiologists blinded to other imaging findings. RESULTS: US is generally accurate in diagnostic imaging of obstructive biliary disease. MRCP and CCT are significantly more accurate only in completing the staging of malignant stenosis. CONCLUSIONS: If the suspicion posed by clinical and laboratory findings is not confirmed at US, the diagnosis must be achieved with the aid of MRCP or--where MRCP does not provide a diagnosis--CCT, so as to select candidates for therapeutic ERCP, PTC or surgery. If laboratory and clinical findings are supported by US, ERCP is required for therapeutic purposes, or--if necessary--surgery is performed.

Treatment of large hepatocellular carcinoma: comparison between techniques and long term results.

PURPOSE: The aim of this study was to compare results over time of Transcatheter Arterial Chemo Embolization (TACE), Percutaneous Ethanol Injection (PEI), Laser Thermal Ablation (LTA) and combined therapy of large Hepatocellular Carcinoma (HCC). MATERIALS AND METHODS: Between 1995 and 2003, 89 cirrhosis patients (51 Child-Pugh A, 38 Child-Pugh B) with at least one nodule of HCC =/> 40 mm, were included in this randomized study; 21 were treated with TACE, 20 with PEI, 29 with LTA and 19 with combined therapy. The total number of HCC nodules was 92 with a mean diameter of 52.9 mm. RESULTS: No major complication occurred in all procedures. CT scan showed that complete necrosis was achieved in 83% of treated nodules (76 out of 92); as a whole, the disease relapsed in 18 (20.2%) patients (disease free interval being 18.2+/-9.4 months). The cumulative survival rates were 69.6%, 25.1% and 9.8% at 12, 36 and 60 months respectively. Univariate analysis of survival showed statistically significant differences in the comparison between Child-Pugh A group vs B (p<0.0001) and between single nodule vs multiple (p=0.0019). Patients subjected to combined therapy and LTA showed a statistically significant longer survival than those treated with TACE and PEI. CONCLUSIONS: LTA proves to be the most effective treatment for HCC < 50 mm, combined therapy is the best choice for nodules =/> 50 mm since complete necrosis is achieved in almost all cases and better total survival in the treated patients.